November Social Media Round-Up—Vaccine Anniversary, Transgender Awareness, and the Corporate Equality Index
Monday, December 04, 2023 - 12:00pm
Thanksgiving may have kicked off the holiday season, but November was chock full of things to celebrate all month long, including Transgender Awareness Week and Veterans Day. On social media, Pfizer’s leadership reflected on those occasions, and our CEO considered the cure for the epidemic of exclusion and celebrated the three-year anniversary of the moonshot heard around the world.
Get caught up below with November’s social media round-up!
From Our Leadership
- CEO Albert Bourla reflects on the anniversary of the COVID-19 vaccine
- Chief Corporate Affairs Officer Sally Susman recognizes Transgender Awareness Week via a conversation with a transgender colleague
- CEO Albert Bourla praises Pfizer’s Chief Technology Officer’s remarks at Amazon Web Service’s #AWSreInvent conference
- Chief People Experience Officer Payal Sahni Becher honors Pfizer’s employees with military service backgrounds on Veterans’ Day
- Albert Bourla shares his speech from the 2023 APEC CEO Summit, in which he discusses the cure for the exclusion epidemic
- Global Chief Diversity, Equity, and Inclusion Officer Jean-Louis Ramcess happily shares Pfizer’s place on the Human Resource Campaign Foundation’s Corporate Equality Index
Recent Updates and Statements
06.27.2024 Autoimmune Diseases Diseases & Conditions Partnerships Research Opportunities to Drive Change in Alopecia Areata 06.24.2024 Employees Partnerships Pfizer Culture Responsibility Pfizer Launches 175 Days of Good—A Global Commitment to Community Volunteerism 06.12.2024 Diversity & Inclusion Employees Pfizer’s Global Asian Alliance Colleague Resource Group Celebrates Asian American Native Hawaiian Pacific Islander (AANHPI) Heritage Month 06.11.2024 Diversity & Inclusion Pfizer Culture 2024 Pride Journal—Together in Pride 06.05.2024 Albert Bourla Cancer Clinical Trials Finance Leadership May Social Media Round-Up—Clinicals Trials Day, the TIME 100, and the Future of Cancer Care